Lastest Insider Transactions Of REGENERON PHARMACEUTICALS, INC. ( REGN ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | 2024-03-13 | Sell | 5,783 | 956.47 | 5,531,290 | 2024-03-15 16:01:02 |
REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | 2024-03-13 | Option Exercise | 20,000 | 399.66 | 7,993,200 | 2024-03-15 16:01:02 |
REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-02-26 | Sell | 1,000 | 990.00 | 990,000 | 2024-02-28 16:04:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Directior | 2024-02-26 | Sell | 1,000 | 992.50 | 992,500 | 2024-02-28 16:04:19 |
REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Directior | 2024-02-26 | Option Exercise | 1,000 | 413.33 | 413,330 | 2024-02-28 16:04:19 |
REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | 2024-02-14 | Sell | 10,434 | 942.28 | 9,831,727 | 2024-02-16 16:15:32 |
REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | 2024-02-09 | Option Exercise | 35,375 | 378.30 | 13,382,510 | 2024-02-13 16:04:28 |
REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Directior | 2024-02-08 | Sell | 1,000 | 950.00 | 950,000 | 2024-02-12 16:02:31 |
REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Directior | 2024-02-08 | Option Exercise | 1,000 | 413.33 | 413,330 | 2024-02-12 16:02:31 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Finance & CFO | 2024-02-09 | Sell | 4,919 | 953.31 | 4,689,320 | 2024-02-12 16:02:02 |
REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-02-07 | Sell | 1,000 | 950.00 | 950,000 | 2024-02-09 16:12:25 |
REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | 2024-02-07 | Sell | 8,037 | 950.35 | 7,637,954 | 2024-02-08 16:02:33 |
REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | 2024-02-02 | Option Exercise | 30,750 | 399.66 | 12,289,545 | 2024-02-06 16:08:32 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-02-02 | Option Exercise | 400 | 378.98 | 151,592 | 2024-02-06 16:08:17 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2024-02-05 | Sell | 1,000 | 934.71 | 934,710 | 2024-02-06 16:08:02 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2024-02-01 | Sell | 100 | 954.22 | 95,422 | 2024-02-05 16:05:50 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2024-02-01 | Sell | 273 | 945.61 | 258,152 | 2024-02-02 16:02:55 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-01-31 | Option Exercise | 400 | 378.98 | 151,592 | 2024-02-02 16:02:11 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2024-01-30 | Sell | 827 | 959.00 | 793,093 | 2024-01-31 16:52:52 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2024-01-30 | Option Exercise | 827 | 380.95 | 315,046 | 2024-01-31 16:52:52 |
REGN | REGENERON PHARMACEUTICALS, INC. | GOLDSTEIN JOSEPH L | Directior | 2024-01-23 | Sell | 2,707 | 950.00 | 2,571,650 | 2024-01-25 16:18:36 |
REGN | REGENERON PHARMACEUTICALS, INC. | GOLDSTEIN JOSEPH L | Directior | 2024-01-23 | Option Exercise | 2,707 | 625.60 | 1,693,499 | 2024-01-25 16:18:36 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2024-01-23 | Option Exercise | 10,000 | 477.67 | 4,776,650 | 2024-01-25 16:17:49 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-01-23 | Option Exercise | 1,600 | 378.98 | 606,368 | 2024-01-25 16:17:25 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-01-17 | Option Exercise | 500 | 378.98 | 189,490 | 2024-01-18 16:02:18 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-01-12 | Option Exercise | 800 | 378.98 | 303,184 | 2024-01-17 16:03:43 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-01-04 | Option Exercise | 500 | 378.98 | 189,490 | 2024-01-08 16:02:01 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2024-01-03 | Option Exercise | 10,000 | 477.67 | 4,776,650 | 2024-01-04 16:22:04 |
REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 2024-01-02 | Sell | 16,848 | 900.00 | 15,163,200 | 2024-01-04 16:20:19 |
REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-01-03 | Option Exercise | 34,000 | 399.66 | 13,588,440 | 2024-01-04 16:19:41 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2024-01-02 | Option Exercise | 1,750 | 378.98 | 663,215 | 2024-01-04 16:19:09 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2024-01-02 | Sell | 274 | 873.91 | 239,451 | 2024-01-04 16:17:56 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2024-01-02 | Sell | 826 | 914.00 | 754,964 | 2024-01-04 16:11:19 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2024-01-02 | Option Exercise | 826 | 380.95 | 314,665 | 2024-01-04 16:11:19 |
REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Directior | 2024-01-02 | Sell | 1,117 | 900.00 | 1,005,300 | 2024-01-04 16:11:18 |
REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Directior | 2024-01-02 | Option Exercise | 1,117 | 391.92 | 437,775 | 2024-01-04 16:11:18 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2024-01-02 | Sell | 100 | 899.90 | 89,990 | 2024-01-04 16:08:51 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-12-27 | Sell | 2,049 | 898.00 | 1,840,002 | 2023-12-29 16:06:46 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-12-27 | Option Exercise | 2,049 | 482.68 | 989,011 | 2023-12-29 16:06:46 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-12-27 | Option Exercise | 1,600 | 378.98 | 606,368 | 2023-12-29 16:05:59 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2023-12-27 | Sell | 2,448 | 856.71 | 2,097,226 | 2023-12-29 16:04:51 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2023-12-21 | Sell | 1,930 | 844.30 | 1,629,502 | 2023-12-26 16:08:29 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-12-12 | Option Exercise | 1,000 | 378.98 | 378,980 | 2023-12-14 16:08:07 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-12-13 | Sell | 610 | 870.00 | 530,700 | 2023-12-14 16:07:40 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-12-13 | Option Exercise | 610 | 376.69 | 229,781 | 2023-12-14 16:07:40 |
REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 2023-12-11 | Option Exercise | 25,155 | 0.00 | 0 | 2023-12-13 16:05:43 |
REGN | REGENERON PHARMACEUTICALS, INC. | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 2023-12-11 | Option Exercise | 25,155 | 0.00 | 0 | 2023-12-13 16:05:34 |
REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | 2023-12-04 | Sell | 6,536 | 817.44 | 5,342,788 | 2023-12-06 16:02:23 |
REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | 2023-12-04 | Option Exercise | 20,000 | 270.43 | 5,408,600 | 2023-12-06 16:02:23 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-12-01 | Sell | 100 | 817.30 | 81,730 | 2023-12-04 16:02:20 |
REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | 2023-11-13 | Sell | 6,492 | 799.17 | 5,188,213 | 2023-11-15 16:02:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | 2023-11-13 | Option Exercise | 20,000 | 270.43 | 5,408,600 | 2023-11-15 16:02:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-11-07 | Sell | 100 | 827.90 | 82,790 | 2023-11-08 16:07:20 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-11-01 | Sell | 1,000 | 783.91 | 783,910 | 2023-11-02 16:03:22 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-11-01 | Option Exercise | 1,000 | 381.40 | 381,400 | 2023-11-02 16:03:22 |
REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Directior | 2023-10-13 | Sell | 1,000 | 850.00 | 850,000 | 2023-10-17 16:06:37 |
REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Directior | 2023-10-13 | Option Exercise | 1,000 | 391.92 | 391,920 | 2023-10-17 16:06:37 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-10-02 | Sell | 1,038 | 827.00 | 858,426 | 2023-10-03 16:04:14 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-10-02 | Option Exercise | 1,038 | 372.46 | 386,613 | 2023-10-03 16:04:14 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-09-01 | Sell | 250 | 834.55 | 208,638 | 2023-09-06 16:03:25 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2023-08-23 | Option Exercise | 7,000 | 399.66 | 2,797,620 | 2023-08-25 16:03:11 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-08-23 | Sell | 223 | 844.00 | 188,212 | 2023-08-25 16:02:53 |
REGN | REGENERON PHARMACEUTICALS, INC. | POON CHRISTINE A | Directior | 2023-08-23 | Sell | 12,280 | 839.97 | 10,314,829 | 2023-08-25 16:02:34 |
REGN | REGENERON PHARMACEUTICALS, INC. | POON CHRISTINE A | Directior | 2023-08-23 | Option Exercise | 12,280 | 273.67 | 3,360,668 | 2023-08-25 16:02:34 |
REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | 2023-08-23 | Sell | 6,197 | 841.71 | 5,216,073 | 2023-08-25 16:02:12 |
REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | 2023-08-23 | Option Exercise | 23,125 | 381.40 | 8,819,875 | 2023-08-25 16:02:12 |
REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | 2023-08-21 | Sell | 11,665 | 840.98 | 9,810,082 | 2023-08-23 16:03:35 |
REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | 2023-08-21 | Option Exercise | 50,000 | 399.66 | 19,983,000 | 2023-08-23 16:03:35 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-08-21 | Sell | 853 | 829.00 | 707,137 | 2023-08-23 16:03:08 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-08-21 | Option Exercise | 853 | 391.92 | 334,308 | 2023-08-23 16:03:08 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-08-10 | Sell | 853 | 789.00 | 673,017 | 2023-08-11 16:13:25 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-08-10 | Option Exercise | 853 | 391.92 | 334,308 | 2023-08-11 16:13:25 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-08-01 | Sell | 100 | 736.59 | 73,659 | 2023-08-03 16:25:28 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-08-01 | Sell | 250 | 744.66 | 186,165 | 2023-08-03 16:02:20 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-07-03 | Sell | 250 | 710.09 | 177,523 | 2023-07-06 16:02:23 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-07-03 | Sell | 100 | 716.88 | 71,688 | 2023-07-06 16:01:43 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-06-01 | Sell | 100 | 735.42 | 73,542 | 2023-06-02 16:14:03 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-06-01 | Sell | 250 | 736.00 | 184,000 | 2023-06-02 16:12:43 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-05-01 | Sell | 100 | 805.33 | 80,533 | 2023-05-03 16:01:17 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-04-21 | Sell | 3,070 | 798.42 | 2,451,150 | 2023-04-24 16:05:04 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-04-21 | Option Exercise | 3,070 | 520.01 | 1,596,431 | 2023-04-24 16:05:04 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-04-03 | Sell | 100 | 819.31 | 81,931 | 2023-04-05 16:01:57 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-04-03 | Sell | 1,100 | 818.80 | 900,680 | 2023-04-05 16:00:59 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-04-03 | Option Exercise | 1,100 | 372.46 | 409,706 | 2023-04-05 16:00:59 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-03-27 | Sell | 1,190 | 823.20 | 979,605 | 2023-03-29 16:07:07 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-03-27 | Option Exercise | 3,800 | 379.60 | 1,442,476 | 2023-03-29 16:07:07 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-03-24 | Sell | 1,240 | 818.00 | 1,014,320 | 2023-03-27 16:43:29 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-03-24 | Option Exercise | 1,240 | 380.95 | 472,378 | 2023-03-27 16:43:29 |
REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | President and Chief Scientific | 2023-03-23 | Sell | 3,656 | 804.26 | 2,940,374 | 2023-03-27 16:41:56 |
REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | 2023-03-23 | Option Exercise | 10,000 | 270.43 | 2,704,300 | 2023-03-27 16:39:22 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2023-03-23 | Sell | 2,192 | 806.47 | 1,767,782 | 2023-03-27 16:37:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-03-01 | Sell | 100 | 762.50 | 76,250 | 2023-03-03 16:03:35 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-03-01 | Sell | 1,100 | 759.89 | 835,879 | 2023-03-03 16:03:08 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-03-01 | Option Exercise | 1,100 | 372.46 | 409,706 | 2023-03-03 16:03:08 |
REGN | REGENERON PHARMACEUTICALS, INC. | VAGELOS P ROY | Directior | 2023-02-22 | Option Exercise | 42,500 | 270.43 | 11,493,275 | 2023-02-24 16:07:17 |
REGN | REGENERON PHARMACEUTICALS, INC. | GOLDSTEIN JOSEPH L | Directior | 2023-02-06 | Sell | 3,613 | 800.00 | 2,890,400 | 2023-02-08 16:16:37 |
REGN | REGENERON PHARMACEUTICALS, INC. | GOLDSTEIN JOSEPH L | Directior | 2023-02-06 | Option Exercise | 3,613 | 482.68 | 1,743,923 | 2023-02-08 16:16:37 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-02-06 | Sell | 3,571 | 797.86 | 2,849,158 | 2023-02-08 16:15:58 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-02-06 | Option Exercise | 3,071 | 520.01 | 1,596,951 | 2023-02-08 16:15:58 |
REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | President and Chief Scientific | 2023-02-06 | Sell | 13,189 | 800.08 | 10,552,255 | 2023-02-08 16:15:24 |
REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | President and Chief Scientific | 2023-02-06 | Sell | 13,189 | 800.08 | 10,552,255 | 2023-02-08 16:15:24 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-02-07 | Sell | 1,000 | 769.04 | 769,040 | 2023-02-08 16:14:27 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-02-07 | Option Exercise | 1,000 | 372.46 | 372,460 | 2023-02-08 16:14:27 |
REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | 2023-02-03 | Option Exercise | 5,000 | 270.43 | 1,352,150 | 2023-02-07 16:10:43 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-02-03 | Sell | 1,021 | 779.00 | 795,359 | 2023-02-07 16:09:53 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2023-02-03 | Option Exercise | 1,021 | 380.95 | 388,950 | 2023-02-07 16:09:53 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-02-03 | Sell | 1,491 | 776.80 | 1,158,204 | 2023-02-07 16:09:21 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2023-02-03 | Option Exercise | 3,000 | 381.92 | 1,145,760 | 2023-02-07 16:09:21 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-02-01 | Sell | 100 | 756.13 | 75,613 | 2023-02-03 16:15:24 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-02-01 | Sell | 1,100 | 752.19 | 827,409 | 2023-02-03 16:13:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-02-01 | Option Exercise | 1,100 | 372.46 | 409,706 | 2023-02-03 16:13:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-01-27 | Sell | 1 | 747.00 | 747 | 2023-01-30 16:11:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-01-27 | Option Exercise | 1 | 520.01 | 520 | 2023-01-30 16:11:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-01-06 | Sell | 3,070 | 747.14 | 2,293,720 | 2023-01-10 16:03:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Directior | 2023-01-06 | Option Exercise | 3,070 | 520.01 | 1,596,431 | 2023-01-10 16:03:48 |
REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Directior | 2023-01-03 | Sell | 100 | 726.29 | 72,629 | 2023-01-05 16:37:26 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-01-03 | Sell | 1,100 | 721.86 | 794,046 | 2023-01-05 16:22:31 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2023-01-03 | Option Exercise | 1,100 | 372.46 | 409,706 | 2023-01-05 16:22:31 |
REGN | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Directior | 2022-12-28 | Sell | 5,758 | 714.11 | 4,111,822 | 2022-12-30 16:10:22 |
REGN | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Directior | 2022-12-28 | Option Exercise | 5,758 | 442.24 | 2,546,410 | 2022-12-30 16:10:22 |
REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | 2022-12-09 | Sell | 264 | 730.17 | 192,765 | 2022-12-13 16:13:26 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2022-12-08 | Sell | 218 | 779.00 | 169,822 | 2022-12-12 16:35:30 |
REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Directior | 2022-12-08 | Option Exercise | 218 | 380.95 | 83,047 | 2022-12-12 16:35:30 |
REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | 2022-12-08 | Option Exercise | 3,000 | 381.92 | 1,145,760 | 2022-12-12 16:34:35 |